3 Top Biotech Stocks to Buy Now
Investing in innovative drugs and therapies that treat patients with highly unmet medical needs can be a rewarding venture. Indeed, year to date, the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) has returned nearly 20%. During the same period, the S&P 500 index has gained just 1.28%. Despite all the disruptions caused by COVID-19, the biotech sector has been consistently outperforming.
While large-cap biotech companies have been doing quite well, investors can frequently find market-beating performance in emerging biotechs developing cutting-edge treatments. Let's look at three top biotech stocks to invest in this month.
Source Fool.com